Assessment of long-term remission of acromegaly following surgery

Journal of Neurosurgery

Volumn 98, Issue 4, 2003, Pages 719-724

  Krieger, Mark D ^b   Couldwell, William T ^b   Weiss, Martin H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

Acromegaly; Growth hormone; Insulin like growth factor I; Pituitary adenoma; Transsphenoidal surgery

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; SOMATOMEDIN;

ACROMEGALY; ADOLESCENT; ADULT; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE TEST; GROWTH HORMONE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS FUNCTION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MICROADENOMA; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

EID: 0345701932     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.4.0719     Document Type: Article

References (56)

1. Abosch A, Tyrrell JB, Lamborn KR, et al: Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418, 1998
2. Arafah BH, Brodkey JS, Kaufman B, et al: Transsphenoidal microsurgery in the treatment of acromegaly and gigantism. J Clin Endocrinol Metab 50:578-585, 1980
3. Arafah BM, Rosenzweig JL, Fenstermaker R, et al: Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. J Lab Clin Med 109:346-354, 1987
4. Aron DC, Tyrrell JB, Wilson CB: Pituitary tumors. Current concepts in diagnosis and management. West J Med 162:340-352, 1995
5. Arosio M, Giovanelli MA, Riva E, et al: Clinical use of pre- and post-surgical evaluation of abnormal GH responses in acromegaly. J Neurosurg 59:402-408, 1983
6. Barkan AL: Acromegaly. Trends Endocrinol Metab 3:205-210, 1992 (Reference unverified)
7. Barkan AL, Beitins IZ, Kelch RP: Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 67:69-73, 1988
8. Barkan AL, Halasz I, Dornfeld KJ, et al: Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 82:3187-3191, 1997
9. Barkan AL, Lloyd RV, Chandler WF, et al: Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995: shrinkage of invasive pituitary macroadenomas and improved surgical remission rate. J Clin Endocrinol Metab 67:1040-1048, 1988
10. Baskin DS, Boggan JE, Wilson CB: Transsphenoidal microsurgical removal of growth hormone-secreting pituitary adenomas. A review of 137 cases. J Neurosurg 56:634-641, 1982
11. Bates AS, Van't Hoff W, Jones JM, et al: An audit of outcome of treatment in acromegaly. Q J Med 86:293-299, 1993
12. Bates AS, Van't Hoff W, Jones PJ, et al: The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81:1169-1172, 1996
13. Bengtsson BA, Eden S, Ernest I, et al: Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327-335, 1988
14. Buchfelder M, Brockmeier S, Fahlbusch R, et al: Recurrence following transsphenoidal surgery for acromegaly. Horm Res 35:113-118, 1991
15. Chun M, Masko GB, Hetelekidis S: Radiotherapy in the treatment of pituitary adenomas. Int J Radiat Oncol Biol Phys 15:305-309, 1988
16. Clemmons DR, Van Wyk JJ, Ridgeway EC, et al: Evaluation of acromegaly by measurement of somatomedin-C. N Engl J Med 301:1138-1142, 1979
17. Couldwell WT, Weiss MH: The transsphenoidal approach, in Apuzzo MLJ (ed): Surgery of the Third Ventricle, ed 2. Baltimore: Williams & Wilkins, 1998, pp 553-574
18. Davis DH, Laws ER Jr, Ilstrup DM, et al: Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg 79:70-75, 1993
19. Dobrashian RD, O'Halloran DJ, Hunt A, et al: Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clin Endocrinol 38:589-593, 1993
20. Fahlbusch R, Honegger J, Buchfelder M: Surgical management of acromegaly. Endocrinol Metab Clin North Am 21:669-692, 1992
21. Freda PU, Wardlaw SL, Post KD: Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 89:353-358, 1998
22. Giannella-Neto D, Wajchenberg BL, Mendonca BB, et al: Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients. J Endocrinol Invest 11:57-60, 1988
23. Giustina A, Barkan A, Casanueva FF, et al: Criteria for cure of acromegaly: a consensus statement. J Clin Endocinol Metab 85:526-529, 2000
24. Grisoli F, Leclercq T, Jaquet P, et al: Transsphenoidal surgery for acromegaly - long-term results in 100 patients. Surg Neurol 23:513-519, 1985
25. Hardy J, Somma M: Acromegaly: surgical treatment by transsphenoidal microsurgical removal of the pituitary adenoma, in Tindall GT, Collins WF (eds): Clinical Management of Pituitary Disorders. New York: Raven Press, 1979, pp 209-217 (Reference unverified)
26. Ho PJ, Barkan AL: Acromegaly, in Bardin CW (ed): Current Therapy in Endocrinology and Metabolism, ed 4. Philadelphia: BC Decker, 1991, pp 38-43 (Reference unverified)
27. Kao PC, Laws ER Jr, Zimmerman D: Somatomedin C/insulin-like growth factor I levels after treatment of acromegaly. Ann Clin Lab Sci 22:95-99, 1992
28. Kim MS, Lee SI, Sim JH: Gamma knife radiosurgery for functioning pituitary microadenoma. Stereotact Funct Neurosurg 72 (Suppl 1):119-124, 1999
29. Kim SH, Huh R, Chang JW, et al: Gamma knife radiosurgery for functioning pituitary adenomas. Stereotact Funct Neurosurg 72 (Suppl 1):101-110, 1999
30. Kjellberg RN, Kliman B, Swisher BJ: Radiosurgery for pituitary adenoma with bragg peak proton beam, in Derome PJ, Jedynak CP, Peillon F (eds): Pituitary Adenomas, Biology, Physiopathology and Treatment: Second European Workshop La Pitie-Salpetriere, Paris. Paris: Asclepios Publishing, 1980, pp 209-217 (Reference unverified)
31. Kramer S: The value of radiation therapy for pituitary and parapituitary tumours. Can Med Assoc J 99:1120-1127, 1968
32. Kreutzer J, Vance ML, Lopes MB, et al: Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86:4072-4077, 2001
33. Lamberts SW, Uitterlinden P, del Pozo E: SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years. J Clin Endocrinol Metab 65:703-710, 1987
34. Landolt AM, Haller D, Lomax N, et al: Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 88:1002-1008, 1998
35. Laws ER Jr, Fode NC, Redmond MJ: Transsphenoidal surgery following unsuccessful prior therapy. An assessment of benefits and risks in 158 patients. J Neurosurg 63:823-829, 1985
36. Laws ER Jr, Vance ML: Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 10:327-336, 1999
37. Leavens ME, Samaan NA, Jesse RH Jr, et al: Clinical and endocrinological evaluation of 16 acromegalic patients treated by transsphenoidal surgery. J Neurosurg 47:853-860, 1977
38. Levitt NS, Ratanjee BD, Abrahamson MJ: Do "so-called" normal growth hormone concentrations (2-5 μg/l) indicate cure in acromegaly? Horm Metab Res 27:185-188, 1995
39. Long H, Beauregard H, Somma M, et al: Surgical outcome after repeated transsphenoidal surgery in acromegaly. J Neurosurg 85:239-247, 1996
40. Losa M, Oeckler R, Schopohl J, et al: Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. J Neurosurg 70:561-567, 1989
41. Melmed S: Acromegaly. N Engl J Med 322:966-977, 1990
42. Melmed S: Tight control of growth hormone: an attainable outcome for acromegaly treatment. J Clin Endocrinol Metab 83:3409-3410, 1998
43. Morange-Ramos I, Regis J, Dufour H, et al: Short-term endocrinological results after gamma knife surgery of pituitary adenomas. Stereotact Funct Neurosurg 70:127-138, 1998
44. Nabarro JDN: Acromegaly. Clin Endocrinol 26:481-512, 1987
45. Rajasoorya C, Holdaway IM, Wrightson P, et al: Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol 41:95-102, 1994
46. Ross DA, Wilson CB: Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J Neurosurg 68:854-867, 1988
47. Schlechter NL, Russell SM, Spencer EM, et al: Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 83:7932-7934, 1986
48. Serri O, Somma M, Comtois R, et al: Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy. J Clin Endocrinol Metab 61:1185-1189, 1985
49. Swearingen B, Barker FG II, Katznelson L, et al: Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426, 1998
50. Thomer MO, Vance ML: Growth hormone, 1988. J Clin Invest 82:745-747, 1988
51. Tindall GT, Oyesiku NM, Watts NB, et al: Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. J Neurosurg 78:205-215, 1993
52. Tucker HS, Grubb SR, Wigand JP, et al: The treatment of acromegaly by transsphenoidal surgery. Arch Intern Med 140:795-802, 1980
53. Urdaneta N, Chessin H, Fisher JJ: Pituitary adenomas and craniopharyngiomas: analysis of 99 cases treated with radiation therapy. Int J Radiat Oncol Biol Phys 1:895-902, 1976
54. Valdemarsson S, Bramnert M, Cronquist S, et al: Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report on 39 patients. J Intern Med 230:49-54, 1991
55. Wass JAH, Thorner MO, Morris DV, et al: Long-term treatment of acromegaly with bromocriptine. Br Med J 1:875-878, 1977
56. Wright AD, Hill DM, Lowry C, et al: Mortality in acromegaly. Q J Med 39:1-16, 1970